Cargando…
Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
Neuroendocrine prostate carcinoma, either co-present with the local adenocarcinoma disease or as a result of transdifferentiation later in time, was described as one major process of emerging resistance to androgen deprivation therapies, and at the clinical level it is consistent with the developmen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313607/ https://www.ncbi.nlm.nih.gov/pubmed/25699233 http://dx.doi.org/10.3389/fonc.2015.00006 |